Skip to main content
53°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Genetic Tech Spn ADR
(NQ:
GENE
)
2.255
+0.032 (+1.42%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Genetic Tech Spn ADR
< Previous
1
2
3
4
5
6
Next >
Genetic Technologies building pathway to profitability
September 27, 2023
--News Direct--
Via
News Direct
Genetic Technologies building pathway to profitability
September 27, 2023
Genetic Technologies Ltd (ASX:GTG; NASDAQ:GENE) CEO Simon Morriss tells Proactive the focus over the next 18 years is putting the pathway in place to see the business on track to profitability. GTG...
Via
TheNewswire.com
GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
September 27, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Cannabis Stock Movers For September 15, 2023
September 15, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report® on Bloomberg TV
September 15, 2023
Via
ACCESSWIRE
Why Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
September 13, 2023
Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares rose 38.7% to $0.1713 in pre-market trading. Shares of Avalo Therapeutics jumped over 45% on Tuesday after the company agreed to divest AVTX-800...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 13, 2023
It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!
Via
InvestorPlace
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
September 12, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Bullish Sentiment Across The Cannabis Space - Check Full Movers For September 11, 2023
September 11, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner
September 11, 2023
Trial to Assess Multi Cancer Genetic Risk Assessment in General Practice
From
Genetic Technologies Ltd
Via
GlobeNewswire
Cannabis Stock Movers For September 6, 2023
September 06, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For September 4, 2023
September 04, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Friday For Marijuana Stocks - AusCann Group Holdings, Affinor Growers Among Top Gainers
September 01, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
September 01, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
September 01, 2023
Via
ACCESSWIRE
Bullish Thursday For Marijuana Stocks - Australis Capital, Choom Holdings Among Top Gainers
August 31, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Annual Results – Momentum Building on our Commercial Plans
August 30, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Cannabis Stock Movers For August 29, 2023
August 29, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Genetic Technologies Limited Announces Updated Investor Presentation
August 09, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
August 04, 2023
On Friday, 73 companies reached new 52-week lows.
Via
Benzinga
Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
July 28, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
July 21, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Cannabis Stock Gainers And Losers From July 14, 2023
July 14, 2023
Via
Benzinga
GeneType featured on U.S. National TV to raise Breast Cancer Awareness
May 23, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
New Publication Validates geneType for Melanoma Risk Assessment
April 28, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Quarterly Business Update – March 2023
April 27, 2023
Driving growth, Expanded Multi-Test Panel and Publications Validating Clinical Utility of geneType
From
Genetic Technologies Ltd
Via
GlobeNewswire
Publication Validates geneType Prostate Cancer Risk Test
April 19, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation
March 27, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Back-to-back Studies Validate geneType Breast Cancer Risk Test
March 13, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 13, 2023
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.